Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE).
Bourgeois S, Deltenre P, Delwaide J, Henrion J, Adler M, Langlet P, Mulkay JP, Nevens F, Brixko C, Moreno C. Bourgeois S, et al. Among authors: langlet p. Acta Gastroenterol Belg. 2014 Dec;77(4):393-400. Acta Gastroenterol Belg. 2014. PMID: 25682628 Free article. Clinical Trial.
The management of patients with mild hepatitis C.
Verslype C, Michielsen P, Adler M, Orlent H, Sprengers D, Delwaide J, D'heygere F, Langlet P, Brenard R, Colle I, Reynaert H, Stärkel P, Henrion J; Steering Committee of the Belgian Association for the Study of the Liver. Verslype C, et al. Among authors: langlet p. Acta Gastroenterol Belg. 2005 Jul-Sep;68(3):314-8. Acta Gastroenterol Belg. 2005. PMID: 16268417 Review.
Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients.
Langlet P, D'Heygere F, Henrion J, Adler M, Delwaide J, Van Vlierberghe H, Mulkay JP, Lasser L, Brenard R, Horsmans Y, Michielsen P, Laureys A, Nevens F. Langlet P, et al. Aliment Pharmacol Ther. 2009 Aug 15;30(4):352-63. doi: 10.1111/j.1365-2036.2009.04052.x. Epub 2009 May 26. Aliment Pharmacol Ther. 2009. PMID: 19485978 Free article. Clinical Trial.
High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.
Francque S, De Maeght S, Adler M, Deltenre P, de Galocsy C, Orlent H, Van Steenbergen W, Bastens B, Wain E, Langlet P, Lasser L, Verlinden W, Van Marck E, Henrion J; Steering Committee of the Belgian Association for the Study of the Liver. Francque S, et al. Among authors: langlet p. Acta Gastroenterol Belg. 2011 Mar;74(1):9-16. Acta Gastroenterol Belg. 2011. PMID: 21563648 Free article.
Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
Colle I, Adler M, Brenard R, Henrion J, Langlet P, Michielsen P, Orlent H, Reynaert H, Sprengers D, Stärkel P, Van Damme P, Verslype C, Delwaide J; Belgian Association for the Study of the Liver. Colle I, et al. Among authors: langlet p. Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):389-420. Acta Gastroenterol Belg. 2007. PMID: 18330099 No abstract available.
A pilot observational survey of hepatitis C in Belgium.
De Maeght S, Henrion J, Bourgeois N, de Galocsy C, Langlet P, Michielsen P, Reynaert H, Robaeys G, Sprengers D, Orlent H, Adler M. De Maeght S, et al. Among authors: langlet p. Acta Gastroenterol Belg. 2008 Jan-Mar;71(1):4-8. Acta Gastroenterol Belg. 2008. PMID: 18396742
Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection.
Horsmans Y, Colle I, Van Vlierberghe H, Langlet P, Adler M, Bourgeois N, Brenard R, Michielsen P, Goossens A, Bruckers L; Belgian Assocation for the Study of the Liver. Horsmans Y, et al. Among authors: langlet p. Acta Gastroenterol Belg. 2008 Jul-Sep;71(3):293-7. Acta Gastroenterol Belg. 2008. PMID: 19198574 Clinical Trial.
Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium.
Degré D, Sersté T, Lasser L, Delwaide J, Starkel P, Laleman W, Langlet P, Reynaert H, Bourgeois S, Vanwolleghem T, Negrin Dastis S, Gustot T, Geerts A, Van Steenkiste C, de Galocsy C, Lepida A, Orlent H, Moreno C. Degré D, et al. Among authors: langlet p. PLoS One. 2017 Jan 26;12(1):e0170933. doi: 10.1371/journal.pone.0170933. eCollection 2017. PLoS One. 2017. PMID: 28125694 Free PMC article.
HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriers.
Deltenre P, Laleman W, Van Gossum M, Lenaerts A, Colle I, Michielsen P, Adler M, Delwaide J, Assene C, Reynaert H, D'Heygere F, Robaeys G, de Galocsy C, Brenard R, Langlet P, Sprengers D, Mairlot MC, Preux C, Lefçbvre V, Orlent H, Henrion J. Deltenre P, et al. Among authors: langlet p. Acta Gastroenterol Belg. 2012 Mar;75(1):35-41. Acta Gastroenterol Belg. 2012. PMID: 22567745 Free article.
37 results